{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T04:18:46Z","timestamp":1727065126581},"reference-count":108,"publisher":"Georg Thieme Verlag KG","issue":"06","funder":[{"name":"German Research Foundation and from the Herzstiftung","award":["BA5158\/4"],"award-info":[{"award-number":["BA5158\/4"]}]},{"name":"TSG-Study"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hamostaseologie"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Coagulation abnormalities are common in patients with COVID-19 and associated with high morbidity and mortality. It became a daily challenge to navigate through these abnormal laboratory findings and deliver the best possible treatment to the patients. The unique character of COVID-19-induced coagulopathy necessitates not only a dynamic follow-up of the patients in terms of hemostatic findings but also the introduction of new diagnostic methods to determine the overall function of the coagulation system in real time. After the recognition of the high risk of thromboembolism in COVID-19, several professional societies published their recommendations regarding anticoagulation in patients with COVID-19. This review summarizes common hemostatic findings in COVID-19 patients and presents the societal recommendations regarding the use of coagulation laboratory findings in clinical decision-making. Although several studies have investigated coagulation parameters in patients with COVID-19, the methodological shortcomings of published studies as well as the differences in employed anticoagulation regimens that have changed over time, depending on national and international guidelines, limit the applicability of these findings in other clinical settings. Accordingly, evidence-based recommendations for diagnostics during acute COVID-19 infection are still lacking. Future studies should verify the role of coagulation parameters as well as viscoelastic methods in the management of patients with COVID-19.<\/jats:p>","DOI":"10.1055\/a-1755-8676","type":"journal-article","created":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T23:25:41Z","timestamp":1651101941000},"page":"409-419","source":"Crossref","is-referenced-by-count":4,"title":["Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature"],"prefix":"10.1055","volume":"42","author":[{"given":"G\u00fcnalp","family":"Uzun","sequence":"additional","affiliation":[{"name":"Center for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Althaus","sequence":"additional","affiliation":[{"name":"Center for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany"},{"name":"Medical Faculty of Tuebingen, Institute for Clinical and Experimental Transfusion Medicine, Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Hammer","sequence":"additional","affiliation":[{"name":"Center for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamam","family":"Bakchoul","sequence":"additional","affiliation":[{"name":"Center for Clinical Transfusion Medicine, University Hospital of Tuebingen, Tuebingen, Germany"},{"name":"Medical Faculty of Tuebingen, Institute for Clinical and Experimental Transfusion Medicine, Tuebingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,4,27]]},"reference":[{"issue":"26","key":"ref1","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMsa2011686","article-title":"Hospitalization and mortality among black patients and white patients with COVID-19","volume":"382","author":"E G Price-Haywood","year":"2020","journal-title":"N Engl J Med"},{"issue":"10","key":"ref2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamainternmed.2020.3539","article-title":"Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy","volume":"180","author":"G Grasselli","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"06","key":"ref3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"J Helms","year":"2020","journal-title":"Intensive Care Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"F A Klok","year":"2020","journal-title":"Thromb Res"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"e2010478","DOI":"10.1001\/jamanetworkopen.2020.10478","article-title":"Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19)","volume":"3","author":"J Nahum","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"07","key":"ref6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"J-F Llitjos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M20-2003","article-title":"Autopsy findings and venous thromboembolism in patients with COVID-19: a prospective cohort study","volume":"173","author":"D Wichmann","year":"2020","journal-title":"Ann Intern Med"},{"issue":"16","key":"ref8","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.jacc.2020.08.041","article-title":"Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19","volume":"76","author":"G N Nadkarni","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"09","key":"ref9","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/jth.15004","article-title":"ISTH DIC subcommittee communication on anticoagulation in COVID-19","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"23","key":"ref10","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"B Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.thromres.2020.12.019","article-title":"Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave","volume":"199","author":"F HJ Kaptein","year":"2021","journal-title":"Thromb Res"},{"issue":"06","key":"ref12","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"M Levi","year":"2020","journal-title":"Lancet Haematol"},{"issue":"06","key":"ref13","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The trinity of COVID-19: immunity, inflammation and intervention","volume":"20","author":"M Z Tay","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"ref14","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"D C Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"issue":"07","key":"ref15","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S2352-3026(21)00105-8","article-title":"COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year","volume":"8","author":"J Leentjens","year":"2021","journal-title":"Lancet Haematol"},{"issue":"02","key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s41030-020-00126-5","article-title":"The interplay between coagulation and inflammation pathways in COVID-19-associated respiratory failure: a narrative review","volume":"6","author":"R Bhattacharyya","year":"2020","journal-title":"Pulm Ther"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"E D Hottz","year":"2020","journal-title":"Blood"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-020-03077-0","article-title":"The unique characteristics of COVID-19 coagulopathy","volume":"24","author":"T Iba","year":"2020","journal-title":"Crit Care"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11739-020-02601-y","article-title":"COVID-19 coagulopathy: is it disseminated intravascular coagulation?","volume":"16","author":"M Levi","year":"2021","journal-title":"Intern Emerg Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2021.02.010","article-title":"Incidence and impact of disseminated intravascular coagulation in COVID-19 a systematic review and meta-analysis","volume":"201","author":"X Zhou","year":"2021","journal-title":"Thromb Res"},{"issue":"12","key":"ref21","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00011-020-01401-6","article-title":"The coagulopathy, endotheliopathy, and vasculitis of COVID-19","volume":"69","author":"T Iba","year":"2020","journal-title":"Inflamm Res"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary embolism and deep vein thrombosis in COVID-19: a systematic review and meta-analysis","volume":"298","author":"Y J Suh","year":"2021","journal-title":"Radiology"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"2101033","DOI":"10.1183\/13993003.01033-2021","article-title":"Prevalence of pulmonary embolism in patients with COVID 19 at the time of hospital admission","volume":"58","author":"M Jevnikar","year":"2021","journal-title":"Eur Respir J"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"e0241329","DOI":"10.1371\/journal.pone.0241329","article-title":"The values of coagulation function in COVID-19 patients","volume":"15","author":"X Jin","year":"2020","journal-title":"PLoS One"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-020-04305-x","article-title":"Characteristics of coagulation alteration in patients with COVID-19","volume":"100","author":"H-C Luo","year":"2021","journal-title":"Ann Hematol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"618929","DOI":"10.3389\/fphys.2021.618929","article-title":"Correlation of coagulation parameters with clinical outcomes during the coronavirus-19 Surge in New York: observational cohort","volume":"12","author":"M Reyes Gil","year":"2021","journal-title":"Front Physiol"},{"issue":"03","key":"ref27","doi-asserted-by":"crossref","first-page":"e0247676","DOI":"10.1371\/journal.pone.0247676","article-title":"Development and validation of a predictive model of in-hospital mortality in COVID-19 patients","volume":"16","author":"D Velasco-Rodr\u00edguez","year":"2021","journal-title":"PLoS One"},{"issue":"07","key":"ref28","doi-asserted-by":"crossref","first-page":"e24537","DOI":"10.1097\/MD.0000000000024537","article-title":"The effect of coagulation factors in 2019 novel coronavirus patients: a systematic review and meta-analysis","volume":"100","author":"G Xiang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ijid.2020.09.021","article-title":"Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19","volume":"100","author":"A Zhang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"632965","DOI":"10.3389\/fcimb.2021.632965","article-title":"Clinical and laboratory profile of hospitalized symptomatic COVID-19 patients: case series study from the first COVID-19 center in the UAE","volume":"11","author":"S Hannawi","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.thromres.2020.09.017","article-title":"Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients","volume":"196","author":"R WG Dujardin","year":"2020","journal-title":"Thromb Res"},{"issue":"17","key":"ref32","first-page":"9161","article-title":"Imbalance between procoagulant factors and natural coagulation inhibitors contributes to hypercoagulability in the critically ill COVID-19 patient: clinical implications","volume":"24","author":"S Voicu","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"01","key":"ref33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00430-020-00696-w","article-title":"Early changes in laboratory parameters are predictors of mortality and ICU admission in patients with COVID-19: a systematic review and meta-analysis","volume":"210","author":"S Kiss","year":"2021","journal-title":"Med Microbiol Immunol (Berl)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"627579","DOI":"10.3389\/fimmu.2021.627579","article-title":"The outcome of critically ill COVID-19 patients is linked to thromboinflammation dominated by the kallikrein\/kinin system","volume":"12","author":"M Lipcsey","year":"2021","journal-title":"Front Immunol"},{"issue":"09","key":"ref35","doi-asserted-by":"crossref","first-page":"E2875","DOI":"10.3390\/jcm9092875","article-title":"Hematological phenotype of COVID-19-induced coagulopathy: far from typical sepsis-induced coagulopathy","volume":"9","author":"Y Umemura","year":"2020","journal-title":"J Clin Med"},{"issue":"08","key":"ref36","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"G Goshua","year":"2020","journal-title":"Lancet Haematol"},{"issue":"01","key":"ref37","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/rth2.12462","article-title":"Prothrombotic changes in patients with COVID-19 are associated with disease severity and mortality","volume":"5","author":"F A von Meijenfeldt","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"e0248230","DOI":"10.1371\/journal.pone.0248230","article-title":"Validation of an admission coagulation panel for risk stratification of COVID-19 patients","volume":"16","author":"D Alabyad","year":"2021","journal-title":"PLoS One"},{"issue":"11","key":"ref39","doi-asserted-by":"crossref","first-page":"E3487","DOI":"10.3390\/jcm9113487","article-title":"COVID-19-associated coagulopathy: biomarkers of thrombin generation and fibrinolysis leading the outcome","volume":"9","author":"M Ranucci","year":"2020","journal-title":"J Clin Med"},{"issue":"10","key":"ref40","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1111\/jth.15043","article-title":"In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID-19 patients on anticoagulation","volume":"18","author":"A Blasi","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref41","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1038\/s41598-021-83822-9","article-title":"Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19","volume":"11","author":"L Chen","year":"2021","journal-title":"Sci Rep"},{"issue":"07","key":"ref42","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1515\/cclm-2020-0188","article-title":"Prominent changes in blood coagulation of patients with SARS-CoV-2 infection","volume":"58","author":"H Han","year":"2020","journal-title":"Clin Chem Lab Med"},{"issue":"08","key":"ref43","doi-asserted-by":"crossref","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","article-title":"A minimal common outcome measure set for COVID-19 clinical research","volume":"20","author":"WHO Working Group on the Clinical Characterisation and Management of COVID-19 Infection","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"18","key":"ref44","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China","volume":"382","author":"W-J Guan","year":"2020","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijid.2021.03.058","article-title":"Clinical characteristics and outcomes of hospitalized COVID-19 patients in a MERS-CoV referral hospital during the peak of the pandemic","volume":"106","author":"M Barry","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"D Wang","year":"2020","journal-title":"JAMA"},{"issue":"04","key":"ref47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1182\/blood.2020006520","article-title":"COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection","volume":"136","author":"H Al-Samkari","year":"2020","journal-title":"Blood"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcrc.2021.03.002","article-title":"The value of D-dimer to predict pulmonary embolism in critically ill COVID-19 patients","volume":"64","author":"M JW van den Berg","year":"2021","journal-title":"J Crit Care"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.7861\/clinmed.2020-0664","article-title":"To scan or not to scan - D-dimers and computed tomography pulmonary angiography in the era of COVID-19","volume":"21","author":"A A Tuck","year":"2021","journal-title":"Clin Med (Lond)"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"109613","DOI":"10.1016\/j.ejrad.2021.109613","article-title":"Association between pulmonary embolism and COVID-19 severe pneumonia: experience from two centers in the core of the infection Italian peak","volume":"137","author":"C Valle","year":"2021","journal-title":"Eur J Radiol"},{"issue":"04","key":"ref51","doi-asserted-by":"crossref","first-page":"2001811","DOI":"10.1183\/13993003.01811-2020","article-title":"Elevated D-dimers and lack of anticoagulation predict PE in severe COVID-19 patients","volume":"56","author":"B Mouhat","year":"2020","journal-title":"Eur Respir J"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.thromres.2020.05.018","article-title":"Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels","volume":"192","author":"P Demelo-Rodr\u00edguez","year":"2020","journal-title":"Thromb Res"},{"issue":"02","key":"ref53","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.mayocp.2020.11.018","article-title":"Arterial thrombotic events in adult inpatients with COVID-19","volume":"96","author":"M Fournier","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"06","key":"ref54","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jvsv.2021.02.018","article-title":"The original and modified Caprini score equally predicts venous thromboembolism in COVID-19 patients","volume":"9","author":"S Tsaplin","year":"2021","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"18","key":"ref55","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/j.jacc.2020.08.070","article-title":"Registry of arterial and venous thromboembolic complications in patients with COVID-19","volume":"76","author":"G Piazza","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"e306","DOI":"10.5114\/amsad.2020.103039","article-title":"A review of the characteristics and outcomes of 900 COVID-19 patients hospitalized at a tertiary care medical center in New Jersey, USA","volume":"5","author":"A Samuel","year":"2020","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.thromres.2020.08.043","article-title":"Asymptomatic deep vein thrombosis in critically ill COVID-19 patients despite therapeutic levels of anti-Xa activity","volume":"196","author":"A Torres-Machorro","year":"2020","journal-title":"Thromb Res"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"4","DOI":"10.18087\/cardio.2021.2.n1532","article-title":"Clinical characteristics and factors associated with poor outcomes in hospitalized patients with novel coronavirus infection COVID-19","volume":"61","author":"S A Boytsov","year":"2021","journal-title":"Kardiologiia"},{"issue":"06","key":"ref59","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/09537104.2020.1768523","article-title":"Hemostatic laboratory derangements in COVID-19 with a focus on platelet count","volume":"31","author":"A Amgalan","year":"2020","journal-title":"Platelets"},{"issue":"02","key":"ref60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bjh.16885","article-title":"Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19)","volume":"190","author":"W Chen","year":"2020","journal-title":"Br J Haematol"},{"issue":"03","key":"ref61","doi-asserted-by":"crossref","first-page":"e0248671","DOI":"10.1371\/journal.pone.0248671","article-title":"Association between thrombocytopenia and 180-day prognosis of COVID-19 patients in intensive care units: a two-center observational study","volume":"16","author":"Y Zhu","year":"2021","journal-title":"PLoS One"},{"issue":"06","key":"ref62","doi-asserted-by":"crossref","first-page":"e13559","DOI":"10.1111\/eci.13559","article-title":"COVID-19 (SARS-CoV-2) infection and thrombotic conditions: a systematic review and meta-analysis","volume":"51","author":"P R Gabbai-Armelin","year":"2021","journal-title":"Eur J Clin Invest"},{"issue":"02","key":"ref63","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2018-02-769000","article-title":"Inflammation, von Willebrand factor, and ADAMTS13","volume":"132","author":"J Chen","year":"2018","journal-title":"Blood"},{"issue":"05","key":"ref64","doi-asserted-by":"crossref","first-page":"e512","DOI":"10.1097\/CCM.0000000000004918","article-title":"von Willebrand factor multimer formation contributes to immunothrombosis in coronavirus disease 2019","volume":"49","author":"A AN Doevelaar","year":"2021","journal-title":"Crit Care Med"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in COVID-19","volume":"383","author":"M Ackermann","year":"2020","journal-title":"N Engl J Med"},{"issue":"03","key":"ref66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s10456-020-09762-6","article-title":"Circulating von Willebrand factor and high molecular weight multimers as markers of endothelial injury predict COVID-19 in-hospital mortality","volume":"24","author":"A Philippe","year":"2021","journal-title":"Angiogenesis"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1055\/s-0041-1723784","article-title":"Low ADAMTS13 activity correlates with increased mortality in COVID-19 patients","volume":"5","author":"J M Sweeney","year":"2021","journal-title":"TH Open"},{"issue":"05","key":"ref68","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.7861\/clinmed.2020-0346","article-title":"Von Willebrand factor (vWF): marker of endothelial damage and thrombotic risk in COVID-19?","volume":"20","author":"E E Ladikou","year":"2020","journal-title":"Clin Med (Lond)"},{"issue":"S 01","key":"ref69","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ijlh.13415","article-title":"ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy","volume":"43","author":"B M Henry","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.thromres.2021.02.012","article-title":"Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19","volume":"201","author":"P L Turecek","year":"2021","journal-title":"Thromb Res"},{"issue":"01","key":"ref71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/09537104.2020.1817361","article-title":"Platelets and renal failure in the SARS-CoV-2 syndrome","volume":"32","author":"M Taha","year":"2021","journal-title":"Platelets"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"e3001109","DOI":"10.1371\/journal.pbio.3001109","article-title":"COVID-19 induces a hyperactive phenotype in circulating platelets","volume":"19","author":"S P Comer","year":"2021","journal-title":"PLoS Biol"},{"issue":"01","key":"ref73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000512007","article-title":"The impact of COVID-19 disease on platelets and coagulation","volume":"88","author":"G D Wool","year":"2021","journal-title":"Pathobiology"},{"issue":"03","key":"ref74","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11239-020-02290-6","article-title":"Immature platelets in patients hospitalized with COVID-19","volume":"51","author":"A Cohen","year":"2021","journal-title":"J Thromb Thrombolysis"},{"issue":"11","key":"ref75","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/CIRCRESAHA.120.317703","article-title":"Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19","volume":"127","author":"Y Zaid","year":"2020","journal-title":"Circ Res"},{"issue":"11","key":"ref76","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"B K Manne","year":"2020","journal-title":"Blood"},{"issue":"02","key":"ref77","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/jth.15587","article-title":"Antibody-mediated procoagulant platelet formation in COVID-19 is AKT dependent","volume":"20","author":"L Pelzl","year":"2022","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref78","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood.2020008762","article-title":"Antibody-induced procoagulant platelets in severe COVID-19 infection","volume":"137","author":"K Althaus","year":"2021","journal-title":"Blood"},{"issue":"01","key":"ref79","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1182\/bloodadvances.2021005210","article-title":"Upregulation of cAMP prevents antibody-mediated thrombus formation in COVID-19","volume":"6","author":"J Zlamal","year":"2022","journal-title":"Blood Adv"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1111\/jth.15283","article-title":"Platelet-activating immune complexes identified in critically ill COVID-19 patients suspected of heparin-induced thrombocytopenia","volume":"19","author":"I Nazy","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"L20","DOI":"10.1152\/ajplung.00312.2002","article-title":"Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury","volume":"285","author":"P Prabhakaran","year":"2003","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.thromres.2020.10.025","article-title":"Prothrombotic disturbances of hemostasis of patients with severe COVID-19: a prospective longitudinal observational study","volume":"197","author":"M Hardy","year":"2021","journal-title":"Thromb Res"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Y Zuo","year":"2021","journal-title":"Sci Rep"},{"issue":"08","key":"ref84","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/jth.14929","article-title":"Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"A C Spyropoulos","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"09","key":"ref86","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"C Nougier","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref87","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1186\/s13054-020-03401-8","article-title":"Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis","volume":"24","author":"J M Kruse","year":"2020","journal-title":"Crit Care"},{"issue":"09","key":"ref88","doi-asserted-by":"crossref","first-page":"e0192","DOI":"10.1097\/CCE.0000000000000192","article-title":"Thromboelastography to detect hypercoagulability and reduced fibrinolysis in coronavirus disease 2019 acute respiratory distress syndrome patients","volume":"2","author":"C Sadd","year":"2020","journal-title":"Crit Care Explor"},{"issue":"06","key":"ref89","doi-asserted-by":"crossref","first-page":"e2011192","DOI":"10.1001\/jamanetworkopen.2020.11192","article-title":"Thromboelastographic results and hypercoagulability syndrome in patients with coronavirus disease 2019 who are critically ill","volume":"3","author":"J R Mortus","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"07","key":"ref90","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"M Panigada","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref91","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/SHK.0000000000001635","article-title":"Fibrinolysis shutdown and thrombosis in a COVID-19 ICU","volume":"55","author":"C Creel-Bulos","year":"2021","journal-title":"Shock"},{"issue":"11","key":"ref92","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1055\/a-1400-6034","article-title":"Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: a descriptive study of fibrinolysis in COVID-19","volume":"121","author":"S Hammer","year":"2021","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref93","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"M Bachler","year":"2021","journal-title":"Br J Anaesth"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"100008","DOI":"10.1016\/j.tru.2020.100008","article-title":"Fibrinolysis shut down in COVID-19 patients: report on two severe cases with potential diagnostic and clinical relevance","volume":"1","author":"T Bakchoul","year":"2020","journal-title":"Thrombosis Update"},{"issue":"01","key":"ref95","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"E G Bouck","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"05","key":"ref96","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/rth2.12372","article-title":"A proposal for staging COVID-19 coagulopathy","volume":"4","author":"J Thachil","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"issue":"01","key":"ref97","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1055\/s-0037-1603929","article-title":"The IMPROVEDD VTE Risk Score: incorporation of D-Dimer into the IMPROVE score to improve venous thromboembolism risk stratification","volume":"1","author":"C M Gibson","year":"2017","journal-title":"TH Open"},{"issue":"04","key":"ref98","first-page":"2123","article-title":"SARS-CoV-2 and finding of vein thrombosis: can IMPROVE and IMPROVEDD scores predict COVID-19 outcomes?","volume":"25","author":"S Greco","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2020.07.035","article-title":"Anti Xa activity after high dose LMWH thrombosis prophylaxis in COVID 19 patients at the intensive care unit","volume":"196","author":"E A Vlot","year":"2020","journal-title":"Thromb Res"},{"issue":"05","key":"ref100","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"03","key":"ref103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1055\/a-1178-3551","article-title":"Coagulopathy in COVID-19 and its implication for safe and efficacious thromboprophylaxis","volume":"40","author":"F Langer","year":"2020","journal-title":"Hamostaseologie"},{"issue":"01","key":"ref105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11239-020-02138-z","article-title":"Thromboembolism and anticoagulant therapy during the COVID-19 pandemic: interim clinical guidance from the anticoagulation forum","volume":"50","author":"G D Barnes","year":"2020","journal-title":"J Thromb Thrombolysis"},{"issue":"03","key":"ref106","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST Guideline and Expert Panel Report","volume":"158","author":"L K Moores","year":"2020","journal-title":"Chest"},{"issue":"04","key":"ref107","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5551\/jat.RPT001","article-title":"COVID-19-related thrombosis in Japan: final report of a questionnaire-based survey in 2020","volume":"28","author":"H Horiuchi","year":"2021","journal-title":"J Atheroscler Thromb"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"631335","DOI":"10.3389\/fmed.2021.631335","article-title":"D-dimer-driven anticoagulation reduces mortality in intubated COVID-19 patients: a cohort study with a propensity-matched analysis","volume":"8","author":"A K Tassiopoulos","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref109","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.thromres.2021.03.031","article-title":"D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19","volume":"201","author":"K Stawiarski","year":"2021","journal-title":"Thromb Res"},{"issue":"S 01","key":"ref110","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ijlh.13230","article-title":"Thromboembolic events and apparent heparin resistance in patients infected with SARS-CoV-2","volume":"42","author":"R Beun","year":"2020","journal-title":"Int J Lab Hematol"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.thromres.2020.09.039","article-title":"Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection","volume":"196","author":"M Trunfio","year":"2020","journal-title":"Thromb Res"},{"issue":"16","key":"ref112","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","article-title":"COVID-19 breakthrough infections in vaccinated health care workers","volume":"385","author":"M Bergwerk","year":"2021","journal-title":"N Engl J Med"}],"container-title":["H\u00e4mostaseologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1755-8676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T03:34:41Z","timestamp":1727062481000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1755-8676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,27]]},"references-count":108,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2022,12,22]]},"published-print":{"date-parts":[[2022,12]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1755-8676","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0720-9355","2567-5761"],"issn-type":[{"type":"print","value":"0720-9355"},{"type":"electronic","value":"2567-5761"}],"subject":[],"published":{"date-parts":[[2022,4,27]]}}}